ZS Pharma, Inc. Deferred Tax Assets, Valuation Allowance

ZS Pharma, Inc. Deferred Tax Assets, Valuation Allowance

ZS Pharma, Inc. had Deferred Tax Assets, Valuation Allowance of $39.55 million as of 2014-12-31, per its 10-K filed 2015-03-13.

Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance

us-gaap:DeferredTaxAssetsValuationAllowance · last filed 2015-03-13

• 2014-12-31: Deferred Tax Assets, Valuation Allowance $39.55M.
• 2013-12-31: Deferred Tax Assets, Valuation Allowance $17.46M.
• 2012-12-31: Deferred Tax Assets, Valuation Allowance $4.72M.